Dr. Tomas E. Liskutin, MD

Dr. Liskutin practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Liskutin's NPI, 1770089005, was assigned on April 4, 2018. Dr. Liskutin graduated from Loyola University of Chicago, Stritch School of Medicine in 2018. Dr. Liskutin holds Utah license 13901333-1205.

Dr. Liskutin's primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Liskutin also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

Dr. Liskutin's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. Dr. Liskutin is also affiliated with Intermountain Medical Center. The medical group on file is Intermountain Health. Dmand AI also links Dr. Liskutin to 1 more hospital, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Liskutin practices, 5 sites in all. Vendor and product names are available with a free account.

Orthopaedic trauma is Dr. Liskutin's primary specialty in the NPI Registry, under taxonomy code 207XX0801X. Dmand AI has Dr. Liskutin's licenses on file in 2 states: Utah and Missouri.

CMS data shows 13 Medicare services from Dr. Liskutin across 1 procedure code in 2024, for 70 Medicare patients. Medicare paid $1,707 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 70 Medicare patients who saw Dr. Liskutin in 2024. The largest group is 75 to 84, with 25 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Liskutin's median patient age at 63, with 53% women.

In 2024, Dr. Liskutin wrote 21 Medicare Part D claims for 16 patients. 100% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $190 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Liskutin for performance year 2024, reported as part of a group. Dr. Liskutin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Hip replacement: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Liskutin, published from 2018 to 2023. 2019 was the busiest year, with 2. The most frequent topics are External Fixators, Ankle Fractures and Bone Plates. Dr. Liskutin has published most often in J Orthop Trauma. Dr. Liskutin's most frequent co-authors are Mitchell A. Bernstein, MD, Hobie D. Summers, MD and William D. Lack, MD.

CMS Open Payments shows 156 general payments to Dr. Liskutin from 11 drug and device companies from 2018 to 2025. Travel and lodging make up the largest share, 36% of the total. Smith & Nephew, Inc. paid the most, $10,153.

Dr. Liskutin graduated from Loyola University of Chicago, Stritch School of Medicine in 2018.